Healthcare provider profile · identity verified

Michael D Krieger, MD

General Practice · HOBART, OK · NPI 1649271727

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	252	91
Atorvastatin Calcium	Atorvastatin Calcium	213	63
Metformin Hcl	Metformin Hcl	164	43
Tamsulosin Hcl	Tamsulosin Hcl	157	43
Pantoprazole Sodium	Pantoprazole Sodium	146	39
Amlodipine Besylate	Amlodipine Besylate	138	34
Gabapentin	Gabapentin	138	35
Levothyroxine Sodium	Levothyroxine Sodium	131	33
Omeprazole	Omeprazole	130	30
Lisinopril	Lisinopril	128	35
Tramadol Hcl	Tramadol Hcl	126	30
Eliquis	Apixaban	119	16
Metoprolol Succinate	Metoprolol Succinate	114	28
Losartan Potassium	Losartan Potassium	109	25
Glipizide Er	Glipizide	97	28
Trazodone Hcl	Trazodone Hcl	95	32
Hydrochlorothiazide	Hydrochlorothiazide	81	22
Simvastatin	Simvastatin	80	19
Jardiance	Empagliflozin	77	15
Azithromycin	Azithromycin	70	54
Ibuprofen	Ibuprofen	66	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	21
Meloxicam	Meloxicam	59	27
Allopurinol	Allopurinol	58	12
Methocarbamol	Methocarbamol	58	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	suppressed
Potassium Chloride	Potassium Chloride	54	16
Rosuvastatin Calcium	Rosuvastatin Calcium	53	17
Furosemide	Furosemide	51	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Carvedilol	Carvedilol	50	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	44
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	48	18
Buspirone Hcl	Buspirone Hcl	44	11
Ropinirole Hcl	Ropinirole Hcl	43	15
Duloxetine Hcl	Duloxetine Hcl	42	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Constulose	Lactulose	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Pregabalin	Pregabalin	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Cefdinir	Cefdinir	32	29
Sertraline Hcl	Sertraline Hcl	32	11
Terazosin Hcl	Terazosin Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	11
Bupropion Xl	Bupropion Hcl	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Famotidine	Famotidine	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	12
Estradiol	Estradiol	26	suppressed
Methylprednisolone	Methylprednisolone	26	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Brilinta	Ticagrelor	21	suppressed
Cephalexin	Cephalexin	21	19
Januvia	Sitagliptin Phosphate	20	suppressed
Levofloxacin	Levofloxacin	20	18
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Celecoxib	Celecoxib	19	suppressed
Fluconazole	Fluconazole	19	16
Promethazine Hcl	Promethazine Hcl	18	13
Spironolactone	Spironolactone	18	suppressed
Temazepam	Temazepam	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Clonidine Hcl	Clonidine Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Prednisone	Prednisone	13	suppressed
Budesonide	Budesonide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Clonidine	Clonidine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error